Guided Therapeutics Announces New Agreement to Promote Sales and Marketing in Russia and Eastern Europe Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced it has...
Guided Therapeutics Provides Progress Update on International Activities .bwalignc {text-align: center} .bwmarginl1 {margin-left: 30.0px} Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic...
New Data Released at European Conference Demonstrates LuViva® Advanced Cervical Scan Detects Cervical Cancer Earlier than Pap and HPV tests. .bwalignc {text-align: center} Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform...
PHOENIX, May 16, 2018 (GLOBE NEWSWIRE) — Guided Therapeutics, Inc. (OTCQB:GTHP) (the “Company”) announced CEO Dr. Gene Cartwright’s interview on Uptick Newswire’s “Stock Day” podcast with Everett Jolly. Guided Therapeutics has developed a cervical cancer...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has signed a definitive, multiyear license agreement with its Turkish distribution partner ITEM for the...
Guided Therapeutics, Inc. (OTCQB: GTHP) reported today that the Company received Regulatory Approval from the Indian Ministry of Health & Family Welfare to allow commercialization of the LuViva device and disposables. The Ministry concluded that the LuViva device...
